Template:Pharmacokinetics of testosterone esters
From HandWiki
| Testosterone ester | Form | Route of administration | Elimination half-life | Mean residence time |
|---|---|---|---|---|
| Testosterone undecanoate | Oil-filled capsules | Oral | 1.6 hours | 3.7 hours |
| Testosterone propionate | Oil solution | Intramuscular injection | 0.8 days | 1.5 days |
| Testosterone enanthate | Castor oil solution | Intramuscular injection | 4.5 days | 8.5 days |
| Testosterone undecanoate | Tea seed oil solution | Intramuscular injection | 20.9 days | 34.9 days |
| Testosterone undecanoate | Castor oil solution | Intramuscular injection | 33.9 days | 36.0 days |
| Testosterone buciclatea | Aqueous suspension | Intramuscular injection | 29.5 days | 60.0 days |
| Notes: Testosterone cypionate has very similar pharmacokinetics to TE. Footnotes: a = Never marketed. Sources: [1][2][3] | ||||
Template documentationReferences
- ↑ Nieschlag, Eberhart; Behre, Hermann M.; Nieschlag, Susan (13 January 2010). Andrology: Male Reproductive Health and Dysfunction. Springer Science & Business Media. pp. 49–54,441–446. ISBN 978-3-540-78355-8. https://books.google.com/books?id=mEgckDNkonUC&pg=PA442.
- ↑ "Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies". Eur. J. Endocrinol. 140 (5): 414–9. 1999. doi:10.1530/eje.0.1400414. PMID 10229906.
- ↑ William Llewellyn (2011). Anabolics. Molecular Nutrition Llc. pp. 212–216. ISBN 978-0-9828280-1-4. https://books.google.com/books?id=afKLA-6wW0oC&pg=PT212.
